References
1. Secretary's Advisory Committee on Genetic Testing. Department of
Health and Human Services. Request for public comment on a proposed classification
methodology for determining level of review for genetic tests. Federal Register
2000:65(236):76643-45.
2. New frontiers in grey literature: GL'99 proceedings.
Fourth International Conference on Grey Literature. Washington, D.C.: GreyNet; 1999.
3. Alberani V, De Castro Pietrangeli P, Mazza AM. The use of grey
literature in health sciences: a preliminary survey. Bull Med Libr Assoc
1990;78:358-63.
4. Baker M. In biomarkers we trust? Nat
Biotechnol 2005;23:297-304.
5. NLM. National Library of Medicine's Health
Technology Assessment Information Resources.
http://www.nlm.nih.gov/nichsr/ehta/chapter10.htm; 2005.
6. NCI. The Early Detection Research Network:
Translational Research to Identify Early Cancer and Cancer Risk. 2005; Third Report.
Return to Contents
Acknowledgments
Prepared for the Agency for Healthcare Research and Quality (Contract No.
290-02-0022).
Kevin M. Chin, MD, MS;
Benjamin Wessler, BA;
Priscilla Chew, MPH; and
Joseph Lau, MD
Tufts-New England Medical Center Evidence-based Practice Center
750 Washington
Street, NEMC #63
Boston, MA 02111
Phone: 617-636-0734
Fax: 617-636-8628
E-mail: kchin@tufts-nemc.org
This report is based on research conducted by the Tufts-New England Medical
Center Evidence-based
Practice Center (EPC) under contract to the Agency for Healthcare Research
and Quality
(AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and conclusions
in this
document are those of the author(s) who are responsible for its contents; the
findings and
conclusions do not necessarily represent the views of AHRQ. Therefore, no statement
in this
article should be construed as an official position of the Agency for Healthcare
Research and
Quality or of the U.S. Department of Health and Human Services.
The information in this report is intended to help health care decision-makers;
patients and
clinicians, health system leaders, and policymakers, make well-informed decisions
and thereby
improve the quality of health care services. This report is not intended to
be a substitute for the
application of clinical judgment. Decisions concerning the provision of clinical
care should consider this report in the same way as any medical reference and
in conjunction with all other
pertinent information, i.e., in the context of available resources and circumstances
presented by
individual patients.
Acknowledgments: The authors would like to thank AHRQ Task Order Officer,
Dr. Gurvaneet Randhawa, for his invaluable contributions throughout the process
of producing this technology assessment.
Return to Contents